Depth analysis revealed that QingHuaZhiXie prescription reversed the imbalance of cytokines by acting on the TLR4/MyD88/NF-κB pathway, contributing to release D-IBS symptoms. The gene discussed is MYD88; the disease is irritable bowel syndrome.